Skip to main content Skip to main navigation menu Skip to site footer

Comparative study on albumin, C-Reactive Protein (CRP) and D-dimer in chronic hemodialysis patients with COVID-19

  • Robinson ,
  • Kevin Gracia Pratama ,
  • Aditiawardana ,

Abstract

Link of Video Abstract: https://youtu.be/-i3vr4qpQUU

 

Background: Chronic kidney disease (CKD) patients on hemodialysis are more susceptible to COVID-19 infections. Mortality and morbidity rate are higher in this population. Thus, it is critical to understand which parameters are associated with mortality in this population. C-reactive protein (CRP), albumin, and d-dimer were shown in several studies to be associated with mortality in COVID-19-infected hemodialysis patients.

Methods: This study was a comparative observational, retrospective study from the medical records of Dr. Soetomo General Hospital in Surabaya, Indonesia. Chronic kidney disease patients on maintenance hemodialysis who tested positive for COVID-19 from June 2020 to January 2021 and underwent treatment in the isolation ward were included in this study. Data were analyzed using SPSS version 21.0 for Windows.

Results: The non-survivor groups have statistically significant lower albumin (2.78 (2.21-3.40) g/dL vs. 3.20 (2.45-3.80) g/dL; p=0.040) and higher CRP (10.40 (4.10-28.6) mg/L vs. 3.20 (0.10-80.0) mg/L; p=0.020) compared to the survivor group (Table 2). D-dimer value has no significant difference between the non-survivor and survivor groups (4,290 (190-18,310) ng/mL vs. 2,630 (190-19,430) ng/mL; p=0.140)

Conclusion: Non-survivor CKD patients with COVID-19 infections have significantly lower serum albumin and higher CRP concentrations. There is no significant difference in D-dimer concentrations in the survivor and non-survivor groups.

References

  1. Ochani R, Asad A, Yasmin F, Shaikh S, Khalid H, Batra S, et al. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 2021;29(1):20-36.
  2. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069-1076.
  3. Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830.
  4. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019;1165:3–15.
  5. Ibernon M, Bueno I, Rodríguez-Farré N, Ruiz P, Sánchez A, Massó E, et al. The impact of COVID-19 in hemodialysis patients: Experience in a hospital dialysis unit. Hemodialysis International. 2021;25(2):205–213.
  6. Shimada N, Shimada H, Itaya Y, Tomino Y. Novel coronavirus disease in patients with end-stage kidney disease. Therapeutic Apheresis and Dialysis. 2021;25(5):544–550.
  7. RAZAK NZA, Aziz AA, Mohamad WHW, Tan MH, Osman S, Bavanandan S. POS-884 CRP Levels and Covid-19 Mortality in Multi Ethnic Population with Chronic Kidney Disease: A Single Centre Experience. Kidney Int Rep. 2022;7(2):S383.
  8. Alves FC, Sun J, Qureshi AR, Dai L, Snaedal S, Bárány P, et al. The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease. PLoS One. 2018;13(1):e0190410.
  9. Rostami M, Mansouritorghabeh H. D-dimer level in COVID-19 infection: a systematic review. Expert Rev Hematol. 2020;13(11):1265–1275.
  10. Hassanein M, Radhakrishnan, Sedor J, Vachharajani T, Vachharajani VT, Augustine J, et al. COVID-19 and the kidney. Cleve Clin J Med. 2020;87(10):619–631.
  11. D’Marco L, Puchades MJ, Romero-Parra M, Gimenez-Civera E, Soler MJ, Ortiz A, et al. Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J. 2020;13(3):297–306.
  12. Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens. 2012;21(6):587-592.
  13. Lamarche C, Iliuta IA, Kitzler T. Infectious Disease Risk in Dialysis Patients: A Transdisciplinary Approach. Can J Kidney Health Dis. 2019;6:2054358119839080.
  14. Kalantar-Zadeh K, Ficociello LH, Bazzanella J, Mullon C, Anger MS. Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis. Int J Nephrol Renovasc Dis. 2021;14:11-21.
  15. Acharya R, Poudel D, Bowers R, Patel A, Schultz E, Bourgeois M, et al. Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study. J Clin Med Res. 2021;13(5):258-267.
  16. Tillett WS, Francis T. Serological Reactions in Pneumonia with A Non-Protein Somatic Fraction of Pneumococcus. J Exp Med. 1930;52(4):561–571.
  17. Mosquera-Sulbaran JA, Pedreañez A, Carrero Y, Callejas D. C-reactive protein as an effector molecule in Covid-19 pathogenesis. Rev Med Virol. 2021;31(6):e2221.
  18. Paliogiannis P, Mangoni AA, Dettori P, Nasrallah GK, Pintus G, Zinellu A. D-dimer concentrations and covid-19 severity: A systematic review and meta-analysis. Front Public Health. 2020;8:432.
  19. Zou R, Chen F, Chen D, Xu CL, Xiong F. Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center. Ren Fail. 2020;42(1):950-957.
  20. Setiawan B, Manurung AKW, Zulizar AA, Budianto W, Sukarnowati TW, Pangarsa EA, et al. Changes in plasma levels of IL-6 and D-dimer in high-risk thrombosis cancer patients undergoing chemotherapy. Bali Medical Journal. 2022;11(1):520-527.
  21. Giri SHN, Aman AK, Hanafie A. Hemostasis changes and its relationship with SOFA score in sepsis patients. Bali Medical Journal. 2019;8(2):496-500.
  22. Kurniawati D, Prasetyo B, Pandu H, Nurdianto AR. Clinical presentation of maternal death with COVID-19 in rural tertiary care center: A retrospective-descriptive Study. Bali Medical Journal. 2022;11(1):87-90.

How to Cite

Robinson, R., Pratama, K. G., & Aditiawardana. (2023). Comparative study on albumin, C-Reactive Protein (CRP) and D-dimer in chronic hemodialysis patients with COVID-19. Bali Medical Journal, 12(2), 2022–2025. https://doi.org/10.15562/bmj.v12i2.4345

HTML
11

Total
7

Share

Search Panel